Share: Facebook Twitter LinkedIn
Activity Provided By:

The Rx Consultant

HIV Infection: An Update on Antiretroviral Therapy – Florida Board-Approved Edition

Access Activity

Overview / Abstract:

Florida Licensees: This issue, together with the Supplement (pages 13 - 19) meets the requirement of the Florida Board of Pharmacy for a CE course on HIV/AIDS.

Thirty seven years after the first case of acquired immunodeficiency syndrome (AIDS) was reported, 36.7 million people world-wide are living with HIV. About 1.8 million new HIV infections and 1 million AIDS-related deaths were reported in 2016. However, there has been significant progress in battling the disease over the last 20 years. Since 2001, the number of new cases decreased by 40% worldwide, and since 2005, AIDS-related deaths have declined by 56%. For the first time in the US, the number of new infections declined 18% between 2008 and 2014.

Due to the availability of potent and better-tolerated antiretroviral
agents (ARVs) that prolong life, the number of people
living with HIV has increased significantly since the late 1990s.
About 1.1 million people in the US are currently living with
HIV infection. People living with HIV now have a similar life
expectancy as the general population. The 50 year old and older
age group accounted for almost one-half (45%) of persons living
with HIV infection in the US in 2014. However, complete viral
suppression with ARV treatment does not fully restore health.

Expiration

Mar 15, 2021

Discipline(s)

Nurse Practitioner , Pharmacy CPE

Format

Monograph, Online

Cost

$10.00

Credits / Hours

2.0

Accreditation

ACPE

Presenters / Authors / Faculty

Elizabeth Sherman, PharmD, AAHIVP
Betty J. Dong, PharmD, FCCP, FASHP, FAPHA, AAHIVP

Activity Specialities / Related Topics

Infectious Disease, Immunology / Immunosuppression, HIV / AIDS

Keywords / Search Terms

Continuing Education Network Inc. AIDS, HIV, antiretroviral agents, ARVs, Florida Board of Pharmacy, The Rx Consultant, HIV prevention, Pre-Exposure Prophylaxis, Post-Exposure Prophylaxis, HIV transmission, Nucleotide Reverse Transcriptase Inhibitors, Nucleoside Reverse Transcriptase Inhibitors

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map